Radiology · 510(k) · 2023

MOZI TPS

Manteia Technologies Co., Ltd.. Cleared by FDA on 10 July 2023 under submission K223724, product code MUJ (system, planning, radiation therapy treatment). What FDA's record says, in FDA's words.

Device record · K223724

  1. Device. MOZI TPSDEVICE
  2. Company. Manteia Technologies Co., Ltd. (CN)COMPANY
  3. Decision. 10 July 2023, 510(k), substantially equivalent (traditional review); received 13 December 2022DECISION
  4. Panel. RadiologyPANEL
  5. Product code. MUJ, System, Planning, Radiation Therapy TreatmentCODE
  6. Regulation. 21 CFR 892.5050, Class IIREG
  7. Source. FDA database entry · decision document (14 pages)SOURCE

Retrieved · the fields above are FDA's; the statement below was copied from the decision document on that day.

What FDA cleared it for

The Indications for Use statement, verbatim, from the decision document.

The MOZI Treatment Planning System (MOZI TPS) is used to plan radiotherapy treatments for patients with malignant or benign diseases. MOZI TPS is used to plan external beam irradiation with photon beams. The Eclipse Treatment Planning System (Eclipse TPS) is used to plan radiotherapy treatments for patients with malignant or benign diseases. Eclipse TPS is used to plan external beam irradiation with photon, electron and proton beams, as well as for internal Irradiation (brachytherapy) treatments. In addition, the Eclipse Proton Eye algorithm is specifically indicated for planning proton treatment of neoplasms of the eye. It is used by radiation oncology department to register multi-modality images and segment (non-contrast) CT images, to generate needed information for Treatment planning, treatment evaluation and treatment adaptation. MIM software is used by trained medical professionals as a tool to aid in evaluation and Information management of digital medical images. The medical image modalities include, but are not limited to, CT, MRI, CR, DX, MG, US, SPECT, PET and XA as supported by ACR/NEMA DICOM 3.0. MIM assists in the following indications:  Receive, transmit, store, retrieve, display, print, and process medical images and DICOM objects.  Create, display and print reports from medical images.  Registration, fusion display, and review of medical images for diagnosis, treatment evaluation, 510(k) Summary 4 / 11 and treatment planning.  Evaluation of cardiac left […]

K223724, FDA decision document · source

What the statement says

Pattern matches on the Indications for Use text. Each line is a fact that the text contains the words, not a finding about the device.

Adverse-event reports in MAUDE, by product code

As of , MAUDE held 807 reports filed against devices carrying product code MUJ. That code is shared by every device of this type, not this device alone, and MAUDE reports are submitted by manufacturers, facilities and the public without FDA verification. The latest reports, in the reporter’s words:

24 September 2026 · Malfunction · MONACO · Elekta Solutions AB · report 3015232217-2026-00031

The customer reported that the SRS Cone plan export for the counter clockwise beam is not being transferred correctly to MOSAIQ.

22 September 2026 · Malfunction · RayStation · RaySearch Laboratories AB (Publ) · report 3007774465-2026-00003

A user was preparing radiotherapy treatment of the right breast for a patient who had previously received RT to the left breast. The user performed a deformable registration of the two CT scans (prior treatment and current) and mapped the dose onto the current planning CT to create a cumulative dose distribution. The user noticed that the dose in the left breast (from the prior treatment) appeared cut off as it was limited by the size of the dose grid used for the prior treatment. The patient […]

22 September 2026 · Malfunction · RayStation · RaySearch Laboratories AB (Publ) · report 3010034862-2026-00003

A user was preparing radiotherapy treatment of the right breast for a patient who had previously received RT to the left breast. The user performed a deformable registration of the two CT scans (prior treatment and current) and mapped the dose onto the current planning CT to create a cumulative dose distribution. The user noticed that the dose in the left breast (from the prior treatment) appeared cut off as it was limited by the size of the dose grid used for the prior treatment. The patient […]

15 July 2026 · Malfunction · PLANONE 1 · COSYLAB, JSC, CONTROL SYSTEM LABORATORY · report 3014425747-2026-00001

DURING TREATMENT PLAN PREPARATION FOR A PATIENT, IT WAS DISCOVERED THAT COUCH SHIFTS (TREATMENT COUCH TRANSLATIONS REQUIRED TO MOVE THE PATIENT FROM THE REFERENCE/SCANNED POSITION TO THE TREATMENT POSITION) DISPLAYED IN PLANONE DIFFERED FROM THOSE DISPLAYED IN ARIA/ECLIPSE WHEN A PLAN CREATED IN PLANONE WAS TRANSFERRED TO ARIA FOR SCHEDULING. NO PATIENT HARM OCCURRED, AS THE INCONSISTENCY WAS IDENTIFIED DURING THE PLAN PREPARATION PHASE BEFORE TREATMENT DELIVERY. INVESTIGATION IDENTIFIED THE […]

2 June 2026 · Malfunction · MONACO · ELEKTA SOLUTIONS AB · report 3015232217-2026-00016

THE CUSTOMER REPORTED THAT THE NUMBERING OF THE FIRST MRI IN MONACO ALWAYS STARTS WITH MR2, AND ONLY THE SECOND MRI THEN BEARS THE NUMBER MR1.

Where this fits

This page is a record, not medical advice and not a safety rating. It copies FDA's fields and FDA's statement, and lists what the statement's text mentions. Read the labeling before relying on any of it.

More devices under product code MUJ, in Radiology, from Manteia Technologies Co., Ltd., or cleared in 2023. The whole record is at FDA AI-enabled medical devices.

A device's authorized use is a sentence the record can be read against. What Apodicta does on a medical record is that reading: every line of a note, a claim or a report proved to its source or held, before it renders.

Show me on one of my files →

This device is authorized for a stated use. See a record read against what it must prove, on your own file.

Show me on my files